Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 1 |
NetGPI | no | yes: 0, no: 1 |
Related structures:
AlphaFold database: E9AIJ4
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 60 | 62 | PF00675 | 0.549 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.640 |
CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.739 |
CLV_PCSK_KEX2_1 | 60 | 62 | PF00082 | 0.549 |
CLV_PCSK_PC1ET2_1 | 101 | 103 | PF00082 | 0.640 |
CLV_PCSK_PC1ET2_1 | 127 | 129 | PF00082 | 0.739 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.629 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.818 |
CLV_PCSK_SKI1_1 | 60 | 64 | PF00082 | 0.549 |
DEG_APCC_DBOX_1 | 60 | 68 | PF00400 | 0.588 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.549 |
DOC_CYCLIN_RxL_1 | 57 | 66 | PF00134 | 0.549 |
DOC_CYCLIN_yCln2_LP_2 | 176 | 182 | PF00134 | 0.801 |
DOC_USP7_UBL2_3 | 119 | 123 | PF12436 | 0.637 |
DOC_WW_Pin1_4 | 196 | 201 | PF00397 | 0.831 |
DOC_WW_Pin1_4 | 222 | 227 | PF00397 | 0.798 |
LIG_14-3-3_CanoR_1 | 18 | 26 | PF00244 | 0.617 |
LIG_14-3-3_CanoR_1 | 187 | 196 | PF00244 | 0.843 |
LIG_Actin_WH2_1 | 60 | 77 | PF00022 | 0.599 |
LIG_AP2alpha_2 | 2 | 4 | PF02296 | 0.549 |
LIG_BIR_III_2 | 163 | 167 | PF00653 | 0.768 |
LIG_CaM_IQ_9 | 111 | 127 | PF13499 | 0.645 |
LIG_EH1_1 | 84 | 92 | PF00400 | 0.579 |
LIG_eIF4E_1 | 170 | 176 | PF01652 | 0.747 |
LIG_LIR_Apic_2 | 199 | 204 | PF02991 | 0.818 |
LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.549 |
LIG_LIR_Nem_3 | 79 | 85 | PF02991 | 0.589 |
LIG_LIR_Nem_3 | 99 | 103 | PF02991 | 0.277 |
LIG_SH2_CRK | 223 | 227 | PF00017 | 0.792 |
LIG_SH2_NCK_1 | 201 | 205 | PF00017 | 0.820 |
LIG_SH2_STAT3 | 232 | 235 | PF00017 | 0.764 |
LIG_SH2_STAT3 | 7 | 10 | PF00017 | 0.549 |
LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.621 |
LIG_SH3_3 | 126 | 132 | PF00018 | 0.770 |
LIG_SH3_3 | 204 | 210 | PF00018 | 0.812 |
LIG_SH3_3 | 65 | 71 | PF00018 | 0.604 |
LIG_SH3_3 | 91 | 97 | PF00018 | 0.623 |
LIG_UBA3_1 | 33 | 40 | PF00899 | 0.549 |
MOD_CK1_1 | 16 | 22 | PF00069 | 0.620 |
MOD_CK2_1 | 196 | 202 | PF00069 | 0.830 |
MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.845 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.811 |
MOD_GlcNHglycan | 226 | 229 | PF01048 | 0.592 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.549 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.549 |
MOD_PIKK_1 | 141 | 147 | PF00454 | 0.881 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.622 |
MOD_Plk_4 | 209 | 215 | PF00069 | 0.805 |
MOD_ProDKin_1 | 196 | 202 | PF00069 | 0.830 |
MOD_ProDKin_1 | 222 | 228 | PF00069 | 0.793 |
MOD_SUMO_for_1 | 118 | 121 | PF00179 | 0.635 |
TRG_DiLeu_BaEn_2 | 201 | 207 | PF01217 | 0.819 |
TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.574 |
TRG_ER_diArg_1 | 106 | 109 | PF00400 | 0.628 |
TRG_ER_diArg_1 | 59 | 61 | PF00400 | 0.549 |
TRG_Pf-PMV_PEXEL_1 | 60 | 65 | PF00026 | 0.594 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
Q9C9R6 | ARATH | 34% | 38% |